During the past decade, Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 29 clinical trials were completed, i.e. on average, 80.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 19 clinical trials were completed. i.e. 158.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak" #1 sponsor was "Pfizer" with 12 trials, followed by "Takeda" with 7 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Bayer" with 4 trials sponsored and "Eli Lilly and Company" with 4 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak" #1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Athersys, Inc" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak" are "Crohn's Disease" (8 trials), "Ulcerative Colitis" (8 trials), "Colitis, Ulcerative" (5 trials), "Crohn Disease" (4 trials) and "Allergic Rhinoconjunctivitis" (2 trials). Many other conditions were trialed in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak" in a lesser frequency.

Most popular intervention types in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak" are "Drug" (47 trials), "Other" (6 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "CP-690,550" (5 trials), "Etrolizumab" (3 trials), "Soticlestat" (3 trials) and "placebo" (3 trials). Other intervention names were less common.

The vast majority of trials in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak" are 48 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Szent Janos Korhaz es Eszak-budai Egyesitett Korhazak, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".